Literature DB >> 16952166

Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation.

Giuseppe Fusai1, Parveen Dhaliwal, Nancy Rolando, Caroline Anne Sabin, David Patch, Brian Ritchie Davidson, Andrew Kenneth Burroughs, Keith Rolles.   

Abstract

Predictive factors for intrahepatic cholestasis after orthotopic liver transplantation (OLT) have not yet been established. We sought to identify the incidence and risk factors associated with prolonged severe intrahepatic cholestasis (PSIC) after OLT. We assessed 428 consecutive patients undergoing their first OLT. PSIC was diagnosed if a serum bilirubin concentration was greater than 100 micromol/L and/or a 3-fold increase of alkaline phosphatase occurred within the first month after OLT and was sustained for at least 1 week in the absence of biliary complications. Multivariable logistic regression identified factors independently associated with PSIC. PSIC developed in 107 patients (25%). Independent risk factors by multivariable analysis were intraoperative transfusion of cryoprecipitate and platelets; nonidentical blood group status; suboptimal organ appearance; inpatient status before transplantation; and bacteraemia in the first month after transplantation. In contrast, acute liver failure, older age, and higher levels of serum sodium and serum potassium were all associated with a reduced likelihood of developing PSIC in the first month. There were 47 deaths in the PSIC group (44%) as opposed to 65 deaths in the non-PSIC group (20%) after OLT. A poor preoperative clinical status in conjunction with a suboptimal graft was associated with PSIC after OLT. Avoidance of suboptimal livers and ABO nonidentical grafts for young patients with poor synthetic function and for pretransplant inpatients may lessen this complication and reduce the associated early mortality. (c) 2006 AASLD

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952166     DOI: 10.1002/lt.20870

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  7 in total

Review 1.  Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner.

Authors:  Daniel Benten; Katharina Staufer; Martina Sterneck
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-25

2.  The effects of intraoperative cryoprecipitate transfusion on acute renal failure following orthotropic liver transplantation.

Authors:  Shuang Liu; Xiaoliang Wang; Yuanshan Lu; Tao Li; Zijun Gong; Tao Sheng; Bin Hu; Zhihai Peng; Xing Sun
Journal:  Hepatol Int       Date:  2013-08-02       Impact factor: 6.047

3.  Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure.

Authors:  Chantal Bémeur; Paul Desjardins; Roger F Butterworth
Journal:  J Nutr Metab       Date:  2010-12-22

4.  Cholangiolithiasis postliver transplantation: Successful treatment utilizing percutaneous transhepatic cholangioscopy and laser lithotripsy.

Authors:  Nariman Nezami; Liliya Benchetrit; Igor Latich; Todd Schlachter
Journal:  Radiol Case Rep       Date:  2019-10-08

5.  Intraoperative cryoprecipitate transfusion and its association with the incidence of biliary complications after liver transplantation--a retrospective cohort study.

Authors:  Shuang Liu; Junwei Fan; Xiaoliang Wang; Zijun Gong; Shuyun Wang; Li Huang; Tonghai Xing; Tao Li; Zhihai Peng; Xing Sun
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

Review 6.  Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.

Authors:  Lewis W Teperman
Journal:  Int J Hepatol       Date:  2013-11-13

7.  Estrogen-Estrogen Receptor α Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression.

Authors:  Ta-Lun Kao; Yao-Li Chen; Yu-Ping Kuan; Wei-Chun Chang; Yu-Chen Ho; Shuyuan Yeh; Long-Bin Jeng; Wen-Lung Ma
Journal:  Cell Transplant       Date:  2017-11       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.